SCHEMBL1830619

SCHEMBL1830619

O=NNC(CS)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57052 1.00
SCHEMBL1775718 1.00
SCHEMBL3263169 0.98
SCHEMBL4543595 0.96 KDM4E (0.47)
SCHEMBL5372700 0.96 KDM4E (0.47)
SCHEMBL218863 0.84 FOLH1 (0.39)
SCHEMBL5729609 0.84 FOLH1 (0.39)
SCHEMBL6398091 0.84 KDM4E (0.42)
SCHEMBL7447971 0.77 ACE (0.47)
SCHEMBL19971886 0.76 TGFBR1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126079-A1 URINARY CATHETER TREATMENT The Regents of The University of Michigan (US) 2023-02-08 EP claimed
EP-4017563-A1 NITRIC OXIDE GENERATING SYSTEMS Nota Laboratories, LLC (US) 2022-06-29 EP claimed
EP-3419683-A1 NITRIC OXIDE GENERATING FORMULATIONS AND KITS The Regents of The University of Michigan (US) 2019-01-02 EP claimed
WO-2017147295-A1 NITRIC OXIDE GENERATING FORMULATIONS AND KITS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-08-31 WO claimed
EP-2107914-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO Arsenal Medical, Inc. (US) 2009-10-14 EP claimed
WO-2008055719-A2 MEDICAL DEVICE CAPABLE OF RELEASING NO ARSENAL MEDICAL, INC. (US) 2008-05-15 WO claimed
EP-1539679-A4 OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2007-07-04 EP claimed
EP-1539134-A4 NITROSATED AND/OR NITROSYLATED CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2007-04-11 EP claimed
EP-1534683-A4 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2005-08-24 EP claimed
EP-1539134-A2 NITROSATED AND/OR NITROSYLATED CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-15 EP claimed
EP-1539679-A2 OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-15 EP claimed
EP-1534683-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-01 EP claimed
WO-2004012686-A2 NITROSATED AND/OR NITROSYLATED URSODEOXYCHOLIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-02-12 WO claimed
WO-2004002420-A2 OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-08 WO claimed
WO-2004002409-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-08 WO claimed
WO-2003103602-A2 NITROSATED AND/OR NITROSYLATED CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2003-12-18 WO claimed
US-6133272-A Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses NITROMED, INC. (US) 2000-10-17 US claimed
WO-1994016740-A1 THE USE OF NITRIC OXIDE-DELIVERING COMPOUNDS FOR THE TREATMENT OR PREVENTION OF ALCOHOLIC LIVER INJURY BRIGHAM AND WOMEN'S HOSPITAL (US) 1994-08-04 WO claimed
US-20250009940-A1 ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-01-09 US disclosed
WO-1994017398-A1 CAPILLARY ZONE ELECTROPHORESIS OF THIOLS AND THEIR DERIVATIVES BRIGHAM AND WOMEN'S HOSPITAL (US) 1994-08-04 WO disclosed